To Evaluate the Safety and Tolerability of Anti-Human CD70 T-Cell Injection in Subjects With Advanced/Metastatic Renal Cancer
Clinical trial NCT07647744 · RECRUITING
Trial details
- NCT number
- NCT07647744
- Sponsor
- Hrain Biotechnology Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-30
- Primary completion
- 2029-06-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.